Clinical Trial: Dual-valve (Mitral and Tricuspid) Edge-to-Edge Therapy for Severe Mitral Regurgitation with Moderate-or-Greater Tricuspid Regurgitation: A Prospective, Single-Center, Single-Arm Study (China)

Posted On: 2026-09-17

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dual-valve (Mitral and Tricuspid) Edge-to-Edge Therapy for Severe Mitral Regurgitation with Moderate-or-Greater Tricuspid Regurgitation: A Prospective, Single-Center, Single-Arm Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132660

Registration Time: 2026/09/17

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342109

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Dual-valve (Mitral and Tricuspid) Edge-to-Edge Therapy for Severe Mitral Regurgitation with Moderate-or-Greater Tricuspid Regurgitation: A Prospective, Single-Center, Single-Arm Study (China)